Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients
- 23 April 2002
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 58 (8) , 1277-1279
- https://doi.org/10.1212/wnl.58.8.1277
Abstract
Levels of the potent pro-inflammatory prostaglandin E2 (PGE2) are elevated in postmortem spinal cords from patients with ALS, and inhibition of a key PGE2-synthesizing enzyme, cylcooxygenase-2, is neuroprotective in an in vitro model of ALS. The authors report that 82% of the patients with ALS studied had 2 to 10 times higher PGE2 levels in CSF compared with normal control subjects. That affected areas of the CNS are inflamed in ALS supports this. CSF PGE2 measurement may be useful in monitoring treatment for ALS.Keywords
This publication has 7 references indexed in Scilit:
- The role of glial cells in Parkinsonʼs diseaseCurrent Opinion in Neurology, 2001
- Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosisAnnals of Neurology, 2001
- Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2Molecular and Cellular Neuroscience, 2000
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral SclerosisJournal of Neurochemistry, 1999
- Cyclooxygenase-2: Molecular Biology, Pharmacology, and NeurobiologyCritical Reviews™ in Neurobiology, 1999
- Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALSGlia, 1998